Skip to content
‹ Back to IndustriesHealthcare

Transparency and Access for Healthcare Consumers

Transparency in healthcare is vital to help avoid or reduce the varying disparities that exist and continue to burden the overall medical field in this country. Technology in healthcare is growing and has mitigated some of these disparities, even helping close some of the gaps that have been magnified. But there is still more progress…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Highway to Health on MarketScale.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Transparency in healthcare is vital to help avoid or reduce the varying disparities that exist and continue to burden the overall medical field in this country. Technology in healthcare is growing and has mitigated some of these disparities, even helping close some of the gaps that have been magnified. But there is still more progress to be made and seen as access remains a top concern.

What kinds of technological advances can help improve healthcare access?

Discussing this subject on the newest episode of Highway to Health, host David Kemp interviewed Paul Ketchel, CEO and Co-Founder of MDSave, a platform that helps healthcare consumers compare and weigh medical costs and prices. The two talked about the state of healthcare today, what areas need improvement, and how his company offers resolutions to some of the issues facing the healthcare industry.

Kemp and Ketchel further explored the topic and talked about …

  1. Ketchel’s background and building a healthcare platform
  2. Ways in which technology is a problem solver
  3. Why and where healthcare technology falls behind in creating access

Ketchel detailed how innovative ideas drive change and how it’s benefitted his own, and naturally his company.

“For me innovation is, you know, using the newest technological advances and tools to solve what has traditionally been very large, difficult problems, or problems we haven’t been able to solve in the past. And fortunately, for companies like mine and maybe unfortunately for the rest of the world, healthcare is full of those problems, and I always tell folks I feel like one thing that’s been disappointing from the view of an innovator is that we’ve not really applied that technology to a lot of areas in healthcare yet,” he said.

He continued, “Things are getting better and we’re trying, but you know I think it’s safe to say we’re probably 20 solid years behind other sectors,” said Ketchel.

Paul Ketchel is the CEO and Co-Founder of MDSave, Inc., which he helped found in 2012. Before co-founding the company, he was the COO of Diagnostix Network Alliance, LLC for two years and had other roles in government relations and business development. Ketchel is an alumnus of University of Tennessee-Knoxville where here he received a degree in political science.

Highway to Health

Part of this channel

Highway to Health

Healthcare innovation conversations for executives and technology buyers.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

AI cuts cardiologists' echocardiogram review time by 46%

AI cuts cardiologists' echocardiogram review time by 46%

Late-breaking research presented November 9 at the American Heart Association's Scientific Sessions 2026 reported that AI-drafted preliminary echocardiogram reports were comparable to human drafts. Cardiologists averaged 4.6 minutes finalizing AI drafts versus 8.5 minutes without AI. The findings are a non-peer-reviewed abstract.

  • 01Cardiologists averaged 4.6 minutes finalizing AI-drafted echo reports versus 8.5 minutes without AI, about 46% less time.
  • 02Cardiologists made substantial changes to 50.6% of AI drafts and 49.7% of human drafts.
  • 03The research used 1,200 echocardiograms from 21 Kaiser Permanente Northern California medical centers.

Nov 9, 2026

After Chicago: Did AI at AHA 2026 Pass Its Own Test?

After Chicago: Did AI at AHA 2026 Pass Its Own Test?

At AHA Scientific Sessions 2026 in Chicago, AI ECHO INSIGHT, WATCH-LV, PARAMOUNT and PROVAR+ showed gains in workflow efficiency, screening and treatment decisions, but none established a reduction in hard clinical events. The takeaway: the next test is proving these tools improve outcomes, especially in high-need populations, by connecting to established care.

  • 01AI ECHO INSIGHT cut echo reads 8.5 to 4.6 minutes, and PARAMOUNT changed treatment decisions, but no AI late-breaker showed fewer hard events.
  • 02ZEUS and Lp(a)HORIZON lowered their target biomarkers without reducing major cardiovascular events, a caution against treating algorithmic accuracy alone as proof of patient benefit.
  • 03Low-technology, team-based interventions such as CATCH in Colombia and Jamaica lowered blood pressure, showing the care systems AI tools must connect to.

Nov 9, 2026

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Access TeleCare pharmacist Ashley Selby describes a telehealth antimicrobial stewardship model sized to each hospital's gaps. Joint Commission Standard MM.09.01.01 and 42 CFR 482.42 require a qualified physician and/or pharmacist leader, not a full-time hire, and a 14-study meta-analysis found telehealth stewardship cut antibiotic days of therapy without changing mortality.

  • 01Joint Commission Standard MM.09.01.01, in force since January 2023, requires a physician and/or pharmacist qualified in infectious diseases or stewardship to lead the program, and its committee note allows remote participation.
  • 02The Board of Pharmacy Specialties counts more than 2,380 BCIDP pharmacists nationally, while many small hospitals still assign stewardship to pharmacists without ID training.
  • 03A 14-study meta-analysis found telehealth stewardship raised guideline adherence and cut antibiotic days of therapy, but did not significantly change mortality.

Nov 9, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512